Best Buy Stocks | Premium & Tested

: Up roughly 394% YTD following the commercial launch of its cancer therapy, Anktiva, in Saudi Arabia and expansion into Europe.

: Up 301% YTD as of April 2026. It is currently the top performer in the S&P 500, benefiting from soaring demand for NAND flash memory used in AI data centers. best buy stocks

: Up over 267% YTD after reporting positive clinical data for its RAS/MAPK pathway-driven cancer treatments. : Up roughly 394% YTD following the commercial